These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 1980775)
21. Octreotide dependency and headache: a case report. May A; Lederbogen S; Diener HC Cephalalgia; 1994 Aug; 14(4):303-4. PubMed ID: 7954762 [TBL] [Abstract][Full Text] [Related]
22. Acute hepatitis after treatment of acromegaly with octreotide. Arosio M; Bazzoni N; Ambrosi B; Faglia G Lancet; 1988 Dec 24-31; 2(8626-8627):1498. PubMed ID: 2904619 [No Abstract] [Full Text] [Related]
23. Sandostatin and carcinoid tumours in France: experience in the Lyon area. Chayvialle JA Digestion; 1990; 45 Suppl 1():23-6. PubMed ID: 1692295 [TBL] [Abstract][Full Text] [Related]
24. Treatment of severe orthostatic hypotension with the somatostatin analogue octreotide. Woo J; Or KH; Teoh R; Nicholls MG Aust N Z J Med; 1990 Dec; 20(6):822-3. PubMed ID: 2291734 [TBL] [Abstract][Full Text] [Related]
25. Proceedings of the discussion: 'Tolerability and safety of Sandostatin'. Popovic V; Chayvialle JA; Wass JA Digestion; 1993; 54 Suppl 1():104-6. PubMed ID: 8359564 [No Abstract] [Full Text] [Related]
27. Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly. McKnight JA; McCance DR; Crothers JG; Atkinson AB BMJ; 1989 Sep; 299(6699):604-5. PubMed ID: 2508821 [No Abstract] [Full Text] [Related]
28. Deal watch: Chiasma and Roche partner in oral peptide drug delivery. Harrison C Nat Rev Drug Discov; 2013 Apr; 12(4):255. PubMed ID: 23535927 [No Abstract] [Full Text] [Related]
29. Acromegaly. Proceedings of the Symposium on Somatostatin Analogues--Peptide Therapy in Action. January 9th, 1989, London. Horm Res; 1990; 33 Suppl 1():1-36. PubMed ID: 2358293 [No Abstract] [Full Text] [Related]
30. Acute pancreatitis after short-term octreotide. Fredenrich A; Sosset C; Bernard JL; Sadoul JL; Freychet P Lancet; 1991 Jul; 338(8758):52-3. PubMed ID: 1676101 [No Abstract] [Full Text] [Related]
33. Gall stones and treatment with octreotide for acromegaly. BMJ; 1989 Nov; 299(6708):1162-3. PubMed ID: 2513036 [No Abstract] [Full Text] [Related]
34. How do clinicians integrate oral octreotide into their treatment plan for acromegaly? Lodish MB Lancet Diabetes Endocrinol; 2022 Feb; 10(2):86-87. PubMed ID: 34953532 [No Abstract] [Full Text] [Related]
35. Octreotide-induced manic episodes in a patient with acromegaly. Fernández-Real JM; Recasens M; Ricart W Ann Intern Med; 2006 May; 144(9):704. PubMed ID: 16670150 [No Abstract] [Full Text] [Related]
36. Heart failure and octreotide in acromegaly. Chanson P; Timsit J; Harris AG Lancet; 1992 Jan; 339(8787):242-3. PubMed ID: 1346193 [No Abstract] [Full Text] [Related]
37. [Osteocalcin: an index of development of acromegaly?]. Oberlin F; Guillemant J; Guillemant S; Loison S; Turpin G Presse Med; 1988 Feb; 17(4):166. PubMed ID: 2894670 [No Abstract] [Full Text] [Related]
38. Acute pancreatitis following octreotide withdrawal. Sadoul JL; Benchimol D; Thyss A; Freychet P Am J Med; 1991 Jun; 90(6):763-4. PubMed ID: 2042694 [No Abstract] [Full Text] [Related]